Early days
Alan Cuthbert was born in Peterborough, the elder son of Thomas William Cuthbert, a railwayman, and Florence Mary (née Griffin), a seamstress. Both parents had been brought up in typical Nottingham homes. One of Alan's grandfathers, Henry Cuthbert, was a starch maker, and the other, Richard Griffin, was a lace maker who on occasion was sent to Russia to set up lace-making machinery. Thomas and Florence moved to Peterborough on the promise that Thomas would be promoted to driver, which eventually happened after a hiatus of several years. Alan was educated at Deacon's Grammar School in Peterborough, having won a Scholarship to enable him to attend. He enjoyed studying mathematics, physics and chemistry (biology was not taught at the school), and early on, decided that he wanted to be a chemist, fascinated by the idea of being able to make novel substances. To pursue this ambition, he enrolled at Leicester College of Technology, where he studied pharmacy, gaining a Pharmaceutical Chemist Diploma in 1952 and a Bachelor of Pharmacy degree, conferred by London University, in 1953. His growing interest in biology led him to the University of St Andrews where he was one of the first students studying on the new Bachelor of Science course in pharmacology, from which he graduated in 1956. Alan was an outstanding student, and while at St Andrews, he won several medals for his academic performance. Faced with the requirement to do military service, he applied for a short service commission in the Royal Navy, where he served as an Instructor Lieutenant between 1956 and 1959. During this period (in 1957) he married Harriet (Hetty) Webster, whom he had met while in St Andrews. The newlyweds lived on the base at HMS Ganges in Suffolk.
During his spell in the Navy, Alan became determined to pursue a career in research, and he began writing letters of introduction to some eminent biologists of the time, including Sir Charles Harrington, Head of the National Institute of Medical Research, and Sir Henry Dale, with whom he spent an inspirational half-day at the Wellcome Foundation. Ironically, given how things were to turn out, in 1959 Alan also enquired about the advertised position of Demonstrator (essentially a Junior Lecturer) in the newly formed Department of Pharmacology at the University of Cambridge. He always treasured the rather curt rejection letter from the then Sheild Professor, Ernest Verney, informing Alan that for the vacant position a medical degree was advisable and a background of at least physiology and anatomy essential.
The School of Pharmacy, University of London
Henry Dale introduced Alan to William Feldberg, who in turn put him in touch with Gladwin Buttle, Professor of Pharmacology at the School of Pharmacy (originally in Bloomsbury Square, and later in Brunswick Square, London). A meeting was arranged for 11.45 p.m. on a Saturday night at King's Cross Station. Buttle took Alan to his Department and showed him an empty room, asking 'Would this be suitable for your needs?' Alan jumped at the offer.
A Pfizer Fellowship was secured to support Alan's PhD research on the chicken amniotic membrane, with additional funds from the Egg Marketing Board. Buttle's supervision was notional at best, but the Department of Pharmacology at 'The Square' housed an extraordinary array of talent, including Bill Bowman, Mike Rand, Geoff West, and Brian Callingham, and provided an ideal research environment. It was during this period that Alan and Hetty's two sons were born-Adrian in 1960 and Bruce in 1962. One of Alan's first papers, on the electrical and mechanical activities of chick amnion, appeared in Nature in 1962, with Alan as sole author (1).* Several further papers on the results of his PhD research followed in the next two years. The behaviour of the amnion is of interest because it is devoid of a nerve supply. Alan showed that the amnion spontaneously generates long-lasting (1-5 s) action potentials, which are accompanied by increases in tension. The electrical activity was apparently generated in response to the release of endogenous acetylcholine, which is present in the amnion. Consistent with this notion, addition of exogenous acetylcholine increased the frequency of both the action potentials and the contractions. Alan further showed that the amnion contains a cholinesterase enzyme, and that, as expected, inhibition of this enzyme caused an increase in the activity of the muscle, presumably by allowing the accumulation of endogenous acetylcholine.
Alan impressed visiting scientists, most notably Edith Bülbring who invited him to undertake some sucrose gap experiments in her laboratory in Oxford. Whilst there Alan met Arnold Burgen, a pharmacologist visiting from Canada, who became the second Sheild Professor at Cambridge in 1962. This contact with Burgen led Alan to apply for, and secure, a Demonstratorship in the Department of Pharmacology at the University of Cambridge in 1963.
The Department of Pharmacology, University of Cambridge
In the few years after he moved to Cambridge, Alan published a number of papers on a variety of topics, including drug actions on veins, modification of drug responses by hydrolytic enzymes, and interactions of drugs with phospholipids, suggesting that Alan was searching for his niche. In conversation much later Alan revealed that he was looking for a topic where the 'readout' was something different from muscle contraction, which was used widely to study drug-receptor interactions. Eventually, he settled on epithelial ion transport, which was very poorly understood at the time (in the late 1960s), and upon which he spent the remainder of his career. His first paper on epithelial ion transport, dealing with effects of antidiuretic hormone (ADH) on frog skin, was published in 1968 (2).
The epithelial sodium ion channel
In the early 1970s Alan began to use the drug amiloride to probe Na + channels (now known as ENaCs and then completely uncharacterized) in epithelia from frog skin and toad bladder, tissues that are remarkably good models for the distal section of the mammalian kidney tubule. Na + ions enter the epithelium at the outer (apical) surface and are then pumped out by Na + ,K + -ATPase at the inner (basolateral) surface. The entry of Na + ions at the apical surface was known to be the rate-limiting step in its transepithelial transport, and Na + transport had been shown to saturate rapidly with increasing apical Na + concentration, suggesting that the density of Na + entry sites might depend on the Na + concentration, a suggestion that Alan was later able to confirm. Amiloride was identified as a potent inhibitor of the entry of Na + into the cells, resulting in an inhibition of transepithelial Na + transport (Eigler et al., 1967) . Interestingly, the concentration of amiloride required to cause a 50% inhibition of Na + transport falls linearly with apical Na + concentration (from 2×10 -7 M at 111 mM to 2×10 -8 M at 1.1 mM), indicating a competitive interaction between amiloride and Na + .
For much of his research on epithelial ion transport Alan used the 'Ussing chamber', which had been introduced by Ussing & Zerahn (1951) . The apparatus consists of two half-chambers filled with equal volumes of physiological saline. Ion transport produces a voltage across the epithelium, which is measured using two electrodes placed near the epithelium. This voltage can be clamped at zero by injecting current, using two additional electrodes placed away from the epithelium. This so-called short-circuit current represents the electrogenic ion transport. In the frog skin or toad bladder the short-circuit current is almost completely blocked at high concentrations of amiloride, indicating that it consists almost entirely of electrogenic Na + transport.
Alan, with his graduate student Wing Shum, used the binding of [ 14 C]amiloride to measure the density of Na + channels in the apical surface of amphibian epithelia. Using the Ussing chamber he could measure amiloride binding at the same time as inhibition of short-circuit current. He was unable to detect a specific component of [ 14 C]amiloride binding in frog skin when the apical surface was bathed in normal Ringer solution (111 mM Na + ). However, when the Na + concentration was reduced to 1.1 mM, thereby raising the apparent affinity of amiloride for the channel (see above), and minimizing non-specific binding, a specific binding component was detected that had the properties expected of Na + entry sites (3) . The density of Na + channels was calculated by determining specific binding of [ 14 C]amiloride at a single radioligand concentration and calculating total binding using the fractional occupancy of the channels, derived from the fractional inhibition of short-circuit current. The Na + channel density determined by this approach was ∼200 μm -2 . In this same study, an attempt was made to construct a binding curve for [ 14 C]amiloride; however, non-specific binding became problematic at high radioligand concentrations.
At around the same time as Alan was carrying out his radioligand binding experiments, Bernd Lindemann and Willy Van Driessche were investigating the Na + entry process in frog skin using current fluctuation analysis (Lindemann & Van Driessche, 1977) . In these studies Na + in the basolateral solution bathing the skin was replaced by K + in order to remove the K + diffusion potential at the basolateral membrane and increase its conductance. Under these conditions, it was argued, the basolateral membrane is effectively electrically transparent so that the apical membrane alone can be electrically clamped. The Clions in the apical solution were replaced by impermeant sulphate so that fluctuations in the membrane conductance were caused by the opening and closing of Na + entry sites only. These fluctuations could be analysed in the frequency domain to give a power density spectrum of the conductance noise. When amiloride was added to the apical solution, new high-frequency components appeared in the current noise. The data revealed that the current passing through Na + entry sites was being interrupted temporarily by the blocking action of the drug, so that the entry site current was chopped into a series of short current pulses. Application of suitable kinetic theory allowed estimates to be made of the entry site conductance (∼6 pS, compared with the 2.5 pS estimated for the Na + channel conductance in the squid giant axon). This important result proves that Na + entry in epithelia occurs by a channel mechanism, since the calculated turnover number of 10 6 s -1 cannot be accommodated by a carrier mechanism. The channel density calculated using current fluctuation analysis was 1 μm -2 at 111 mM Na + , increasing at lower Na + concentrations. By extrapolation, the density at zero Na + was estimated to be 50 μm -2 , close to the value reported by Alan, whose experiments were carried out under different conditions and on skin from a different species of frog. It is also important to bear in mind that noise analysis gives the number of channels that are open or blocked by amiloride at a given Na + concentration. If some sites remain closed at zero Na + then the total channel density will be underestimated. On the other hand, binding measurements give densities based on the number of channels that display the correct characteristics, so that the density of functional channels may be overestimated.
In the mid-1970s, Alan used [ 14 C]amiloride binding to explore the effects on transepithelial Na + transport of the hormones aldosterone and ADH. Both hormones cause an increase in Na + transport, though it was clear at the time that their mechanisms of action must be different. The effect of aldosterone, acting from the basolateral side, occurs over a period of several hours and involves the formation of specific mRNA species. In contrast, the effect of ADH begins after only a few minutes, and unlike aldosterone is accompanied by a significant increase in water permeability. It was already becoming clear that aldosterone acts via nuclear receptors, whereas the action of ADH involved the intracellular generation of cAMP. Alan showed that aldosterone caused an increase in Na + channel density in isolated toad bladder epithelial cells, which likely explains the observed increase in Na + transport across the intact epithelium (4). This effect of aldosterone could be prevented by inhibitors of protein synthesis (cycloheximide) or of DNA-dependent RNA synthesis (actinomycin D). ADH, on the other hand, had no effect on Na + channel density in toad bladder epithelial cells (4); rather, it increased the mean single-channel current and reduced the apparent affinity of amiloride for the channel. These results were taken to indicate an ADH-stimulated increase in the mean channel open time.
In 1973, Alan was promoted on the basis of his research to the position of Reader. Much later he described this position as 'the best job in Cambridge', because at the time Readers, of whom there were only a small number, were protected from administration and College teaching, the aim being to allow them to spend the majority of their time pursuing their research uninterrupted. Alan relished the resulting freedom, although Departmental and University administration gradually began to make increasing demands on his time.
I first met Alan in 1976, when I asked him to take me on as his graduate student. I did so after attending his fascinating final-year lectures on epithelial ion transport, which included a description of his own work on the epithelial Na + channel, some of which is described above. He was a tall, imposing figure, and at first I found him rather forbidding; however, he was an outstanding supervisor-providing the opportunity to work independently but also offering support when it was needed. He also had a good sense of humour, which made interacting with him enjoyable. He spent as much time in the lab as he could, doing experiments with cigarette in hand.
[ 14 C]Amiloride is not an ideal ligand for the epithelial Na + channel, largely because its specific activity is low (54 Ci mol -1 ), necessitating the use of large areas of epithelium, not to mention meticulous experimental technique, to generate useable binding data. Alan decided to turn to another Na + channel ligand, benzamil, which has a ten-fold higher affinity for the Na + channel than amiloride, 10 9 M -1 at 1.1 mM Na + . The molecule also has sites at which it can be stably tritiated, potentially generating a radioligand with much greater specific activity. After a few false starts, Alan and I synthesized [ 3 H]benzamil with tritium at the meta position on the phenyl ring, and with a specific activity of 21,000 Ci mol -1 . Using this radioligand, we were able to construct complete binding curves at 1.1 mM Na + using ∼1 cm 2 sheets of frog skin epithelium under open circuit conditions. The dissociation constant for binding was ∼1 nM and the calculated channel density was 130 μm -2 , intermediate between the values determined using [ 14 C]amiloride binding and noise analysis (5).
The availability of [ 3 H]benzamil made it possible to examine the properties of binding in homogenates of mammalian kidney, with a view to using this tissue as a source for the eventual solubilization and isolation of the Na + channel. Alan and I carried out binding studies with rat kidney membrane fractions in an attempt to detect a binding component that might represent the Na + channel. We detected a specific binding component that had an affinity constant of 6×10 7 M -1 at 111 mM Na + , close to the value determined in frog skin (5×10 7 M -1 ) (6) . On the other hand, the affinity constant for amiloride, determined via displacement of [ 3 H]benzamil binding, was 1×10 5 M -1 , much lower than the value in frog skin (5×10 6 M -1 ), though similar to the affinity estimated from the concentration dependence of inhibition of Na + transport in the isolated perfused distal tubule. Surprisingly, the apparent affinity of [ 3 H]benzamil for its binding site was not affected by Na + concentration; nor was the binding capacity affected by aldosterone, raising doubts about the identity of the binding site. Radiation inactivation analysis (carried out in collaboration with Clive Ellory) was used to provide an estimate of the molecular mass of the binding site (650 kDa), and it was shown that binding was retained after solubilization of the tissue with digitonin. However, because of the lack of clarity about the nature of the binding site, no further attempts were made to isolate it. Indeed, it was only much later, in 1994, that the Na + channel (ENaC) was shown to be a heterotrimer of molecular mass ∼220 kDa, one-third the size that we observed. Intriguingly, functional evidence was presented later by Dale Benos (Department of Physiology and Biophysics, University of Alabama at Birmingham) (Ismailov et al., 1996) that the channel operated as a trimer, and my own atomic force microscopy analysis (with Andrew Stewart) also indicated that the recombinant ENaC could assemble as a trimer (Stewart et al., 2011) . So Alan and I might have given up too soon on the renal benzamil binding site.
Alan and I also used [ 3 H]benzamil binding to study the effects of salt depletion on Na + transport in the chicken coprodaeum (with Erik Skadhauge and Niels Bindslev). It was known that the epithelium lining the coprodaeum develops an amiloride-sensitive Na + transport if birds are fed on salt-deficient diets. By comparing [ 3 H]benzamil binding to homogenates of coprodaeal epithelium with binding to intact epithelia, we were able to show that only a small percentage of the binding sites (presumed to be Na + channels) reside on the apical surface of the cells, and that there is a large intracellular pool of channels. Upon salt depletion the tissue apparently responds by inserting more channels into the apical membrane, which presumably accounts for the significant increase in Na + capture by the tissue (7) .
The significance of Alan's work on the epithelial Na + channel, for which he was elected Fellow of the Royal Society in 1982, was that it shed important new light on how the properties of these channels are modified by hormones such as aldosterone and ADH, and thereby increased our understanding of how diuretics affect kidney function.
Sheild Professor of Pharmacology
Alan was elected Sheild Professor and Head of the Department of Pharmacology in 1979. His two major goals as Head of Department were to establish the Department's financial independence and to find it a new home. Over the years, the Department had been poorly served by the University. Initially, it had only a few rooms in the Physiological Laboratory where it carried out its research, and held practical classes for medical and veterinary students. Arnold Burgen secured support from the Wellcome Trust for a wooden building erected on the lawn in front of the Department of Botany. This new structure, known as the Dixon Building, or more colloquially the Dixon Hut, more than doubled the research space available to the Department, but a significant fraction of the new building was still occupied by teaching laboratories. In the late 1970s the University provided more teaching space, which consisted of the teaching laboratory formerly occupied by the Department of Metallurgy. New research laboratories, also funded by the Wellcome Trust, were built on the Addenbrooke's Hospital site, about three miles from the city centre. Consequently, staff had to cycle up and down Hills Road to deliver lectures and run practical classes. This was clearly unsatisfactory, and Alan worked enormously hard over several years to move the Department to the centre of town. Eventually, funds were secured (through the sale of the old building and a loan of more than £1 million from the University) and plans for a new building drawn up. True to form, some members of the University objected to the building, on the grounds that it was a 'design-build' project, and therefore not of sufficient architectural merit. As a consequence, Alan had to present himself at Senate House to defend the project, and there was then a vote by the University's governing body, the Regent House, which fortunately was won. Finally, the Department moved into the new building in 1989. (Figure 1 shows HRH the Duke of Edinburgh visiting the building in 1991.) The relocation facilitated interactions with other University departments, as well as with the pharmaceutical industry, via the embedded Glaxo Institute of Applied Pharmacology (headed by Patrick Humphrey). Rent paid by Glaxo allowed the Department to pay off its debt to the University and to build a new tea room and offices on the top floor. As it turned out, despite its supposed architectural shortcomings, the building proved ideal for the Department's needs and represents Alan's lasting legacy to us. It has proven to be remarkably flexible space, and is currently undergoing extensive refurbishment to provide improved accommodation for the future.
Kallikrein, kinins and other peptides
In 1980-81 Harry Margolius (Department of Pharmacology, Medical University of South Carolina) spent a sabbatical year in Alan's lab in Cambridge, and thus began a collaboration that was to last for several years, as well as a lifelong friendship. Harry was interested in kallikrein and kinins and their potential role in the control of blood pressure. It was known that the mammalian colon contains kallikrein, and that the activity of kallikrein could be increased by aldosterone. Harry had also shown that the mammalian glandular enzyme and a kallikreinlike enzymatic activity discovered in the toad bladder are inhibited by amiloride. Further the tissues in which amiloride blocks Na + transport (e.g. the renal distal nephron, salivary duct, and colon) all contain high concentrations of kallikrein, and inhibitors of glandular kallikrein also inhibit Na + reabsorption across the toad bladder epithelium. This combined evidence suggested that the kinin products of kallikreins might have significant effects on Na + transport across epithelia. Alan and Harry set out to test this idea.
The tissue chosen for the experiments on kinins was the descending rat colon. The driving force for ion transport in this tissue is the basolaterally located Na + ,K + -ATPase. The Clions enter the cells from the basolateral side using the Na + ,K + ,2Clcotransporter, with the inward Na + gradient causing the intracellular Clconcentration to rise above its electrochemical equilibrium concentration. Clions then leave through the apical face of the cell through cystic fibrosis transmembrane conductance regulator (CFTR) channels. Agonists acting through cAMP produce sustained Clsecretory responses by activating CFTR and, indirectly, the cotransporter. Activation of cAMP-sensitive K + channels may also produce a small K + secretory current. Agents which increase the intracellular Ca 2+ concentration activate Ca 2+sensitive K + channels, and thereby increase the electrical gradient for Clloss from the cells.
Alan and Harry showed that the addition of bradykinin or lysylbradykinin (LBK) to the basolateral side of rat colon epithelia caused a rapid and short-lived increase in short-circuit current (8) . Alan later showed that these kinins also cause a separate sustained response. The transient and sustained responses are mediated through B 2 and B 1 bradykinin receptors, respectively. Removal of Clfrom the bathing solution significantly reduced the responses, as did addition of blockers of the Na + ,K + ,2Clcotransporter piretanide or furosemide, and short-circuit current and net Clflux were almost equivalent. The current must therefore be caused largely by Clsecretion, with no apparent involvement of Na + in the kininmediated effect. Alan also investigated the complex second messenger systems involved in these responses. Activation of B 2 receptors results in a transient increase in intracellular Ca 2+ , which precedes the increase in Clsecretion. Removal of Ca 2+ ions from the bathing fluid attenuates the response to kinins, indicating a requirement for an intracellular Ca 2+ signal. LBK was shown to cause the release of the prostaglandins PGE 2 , PGF 2α and TXA 2 from both the epithelium itself and from the submucosa. Additionally, the transport response was reduced by inhibitors of prostaglandin synthesis, such as indomethacin and piroxicam. The released prostaglandins cause an increase in intracellular cAMP concentration via stimulation of adenylyl cyclase. However, colonic epithelia from fatty acid-deficient rats still respond to kinins with an increase in Clsecretion, although prostaglandin release is absent. Hence, the prostaglandin/cAMP cascade has a permissive, but not obligatory, role in kinin-dependent Clsecretion. Notably, Alan showed subsequently that kinins were also able to stimulate Clsecretion in cultured human colonic cell lines, e.g. HCA-7 (9).
What is the significance of Alan's work on kinins? In the gut, secreted Clwill be accompanied by Na + and water; hence, Clsecretion is associated with the generation of a watery solution characteristic of secretory diarrhoea. Given the transient nature of the B 2 receptor-mediated component of the secretory response to kinins, and the fact that other agents such as vasoactive intestinal peptide and histamine also produce similar secretory responses, a major role for kinins in diarrhoeas seems unlikely, although they may be involved in controlling the microenvironment at the intestinal surface. The sustained B 1 receptor-mediated effect might be more significant. Indeed B 1 receptors have been shown to be upregulated in chemically induced colitis, and abnormal kallikrein levels have been associated with intestinal disorders. Kinin effects at B 1 receptors might therefore play a role in conditions such as colitis and irritable bowel disease.
In addition to the kinins, Alan studied the effects of various other peptides on gut epithelial ion transport, along with Helen Cox. These peptides included angiotensin II (10), neuropeptides Y and YY, vasoactive intestinal peptide, and somatostatin. In contrast to the kinins, these peptides had anti-secretory effects in the colon, although angiotensin II increased Clsecretion in the jejunum. As with the kinins, there was evidence that the generation of prostaglandins was involved in these effects.
Hypersensitivity reactions in the gut epithelium
In the mid-to late 1980s, Alan (with Alan Baird) examined hypersensitivity responses of the gut epithelium, which are likely involved in allergic reactions. During a chance meeting, Robin Coombs (Department of Pathology, University of Cambridge) related to Alan how guinea pigs would thrive if given cow's milk to drink for a couple of weeks, but after they had been returned to water intake, a few millilitres of milk instilled into the trachea would trigger anaphylaxis. Alan showed that a colonic epithelium taken from a milksensitized animal would respond to a few drops of cow's milk (added on the basolateral side) with a massive Clsecretory response (11). He also showed that β-lactoglobulin was the antigenic stimulus, and, subsequently, that gut mast cells were involved (e.g. the H 1 receptor antagonist mepyramine blocked the response). Epithelia from water-drinking animals could also be passively sensitized by exposure to serum from milk-fed animals. Furthermore, a similar response could be evoked by exposure of colon preparations taken from rats infected with the nematode Nippostrongylus brasiliensis to worm antigen (12). Alan speculated that the secretory response might be involved in promoting rejection of the nematodes during secondary infection.
Cystic fibrosis
Literature from Germany and Switzerland in the 18th century warned 'Wehe dem Kind, das beim Kuß auf die Stirn salzig schmeckt, es ist verhext und muss bald sterben' ('Woe to the child who tastes salty from a kiss on the brow, for he is cursed and soon must die'). This was an early recognition of the connection between salty sweat and cystic fibrosis (CF). CF is a lethal, recessive, genetic disease affecting approximately one in 2500 live births among Caucasians (Boucher, 2007) . The CF gene encodes CFTR, a cAMP/PKA-dependent, ATPrequiring, membrane chloride ion channel, generally found in the apical membranes of many secreting epithelia, including the colon (see above). There are currently more than 1700 known mutations affecting CFTR, many of which give rise to a disease phenotype. Around 75% of CF alleles contain the F508 mutation which lacks the normal phenylalanine residue at position 508. This altered protein is poorly trafficked to the correct location in the cell and is generally destroyed by the proteasome. In addition, the small amount that does reach the correct location functions poorly. In CF, the airways are coated with a thick, sticky mucus that reduces ciliary activity and predisposes to bacterial infection. The pancreas, liver, kidneys, and intestine are also affected. Major long-term lung problems, and especially bacterial infections, are the cause of death in 80% of CF patients. The CF gene was cloned in 1989, an event that triggered an explosion in research aimed at understanding the mechanisms underlying the disease and at finding a cure. Original strategies centred on gene therapy, and Alan was to play a key part in early work in this area.
The secretory coil of the sweat gland secretes a near-isotonic NaCl solution. This solution then passes into the reabsorbing duct, which has a low water permeability. There, absorption of salt normally creates a hypotonic sweat. It was shown in 1983 by Paul Quinton (then in the Division of Biomedical Sciences, University of California, Riverside) that in CF the duct has a very low Clpermeability (now known to be caused by mutations in CFTR) so that salt could not be reabsorbed (Quinton, 1983) ; hence the salty sweat seen in CF patients. In 1988, Alan, with David Brayden, published a paper on ion transport in cultured human eccrine sweat glands, grown as sheets on permeable supports. He showed that the cells had characteristics of the ducts and transported Na + in an amiloride-sensitive manner (13) . Na + transport was shown to be stimulated by both the muscarinic agonist carbachol and by LBK. In contrast to its behaviour in the colon, the effect of the kinin was insensitive to cyclooxygenase inhibition. In this paper Alan alludes to the potential utility of this preparation in studying the ion transport defect in CF. In a follow-up paper in 1990 (in collaboration with John Wallwork of Papworth Hospital), he reported an apparent decrease in affinity of the Na + channel for amiloride in cultured sweat glands from CF patients, indicating some form of interaction between the channel and CFTR (14) . Using patch clamp analysis (with Robert Henderson) he found no difference between the behaviour of high-conductance Ca 2+ -activated K + channels in normal and CF sweat glands, although a low-conductance, outwardly rectifying K + channel was seen more often in CF than in normal sweat glands.
In 1993, Alan was part of a group, including Christopher Higgins (Imperial Cancer Research Fund Laboratories, University of Oxford) and Martin Evans and Bill Colledge (Wellcome/CRC Institute of Cancer and Developmental Biology, University of Cambridge) that showed that the ion transport defect in the trachea of cystic fibrosis transgenic mice could be corrected by treatment of the mice with liposomes containing the wild type gene (15) . Alan went on to show that trachea, caeca, and colons from mice created by Evans and Colledge in which the CFTR gene was disrupted lacked a cAMP-stimulated Clchannel, and that a F508 mouse model had similar transport deficiency. Furthermore, colons from CF mice did not respond to LBK with an increase in Clsecretion. The same group was able to show that ion transport in the nasal epithelium of CF mice could be normalized by liposome-mediated CFTR gene transfer (16), and an attempt to transfer the method to humans was partially successful (17) . The transient nature of the beneficial effects of gene transfer in mice represented a significant challenge to its potential therapeutic use in the treatment of CF. Importantly in this context, it was shown that the rescue of ion transport in the mouse trachea could be replicated by administration of a second CFTR-liposome dose (18) .
At the time when Alan and colleagues were carrying out these experiments, there was great optimism that gene therapy might become a clinically viable therapy for CF. Furthermore, it was shown that to prevent the lung manifestations of CF, only 5-10% of normal CFTR gene expression is needed. Unfortunately, the promise of gene therapy for CF has not been realized. Multiple approaches have been tested for gene transfer, including liposomes, as in the experiments described above, and viral vectors. However, both methods were found to be relatively inefficient treatment options, mainly because very few cells take up the vector and express the gene, so the treatment has little effect. The field turned instead to small molecules as potential therapeutic agents. Alan himself explored the effects of various compounds. These included duramycin, which forms channels in epithelial membranes; phenanthrolines and benzoquinolones, which are potential CFTR channel openers; 1-ethyl-2-benzimidazolone (EBIO), a potential stimulator of Clsecretion; and lubiprostone, which stimulates Clsecretion via ClC-2 Clchannels. Alan's experiments on lubiprostone were carried out in collaboration with Jeffrey Wine (Cystic Fibrosis Research Laboratory, Stanford University) and involved not only the familiar short-circuit current technique but also studies of fluid secretion from the tracheal submucosal glands of sheep, pigs, and humans (19). Wine had shown that fluid secretion rates of single glands in response to various mediators can be measured by trapping the mucus secretions in an oil layer, where they form spherical bubbles that can be optically measured over a suitable time-course. Alan paid an extended visit to Stanford to learn the technique.
Unfortunately, none of the compounds tested by Alan made it to the clinic. Nevertheless, effective small-molecule therapies are now becoming available (Kuk & Taylor-Cousar, 2015) , although at the time of writing their very high prices are causing controversy and restricting their use. Ivacaftor, developed by Vertex Pharmaceuticals, is effective in CF caused by the G551D mutation, which accounts for 4-5% of cases. It is also included in a combination drug, lumacaftor/ivacaftor, which is also effective in CF caused by the much more common F508 mutation. In the case of the G551D mutant, the protein is trafficked to the cell surface, but once there cannot transport Cl -. Ivacaftor, a so-called 'potentiator', binds to the channels directly and increases their open probability. Lumacaftor, a so-called 'corrector', acts as a chaperone during protein folding and increases the delivery of CFTR to the cell surface. He also pushed hard to drive up academic standards and to ensure that the College finally rid itself of any residual feelings of insecurity that a 'new' College inevitably suffers. I was a Fellow of the College at the time, and witnessed his frustrations, even his irritation, with what he often saw as the ponderous democracy of Governing Body, and his impatience with those who did not agree with his vision for the College.
Alan was the first Master of Fitzwilliam to invite students regularly to the Lodge, and Hetty was hugely supportive in these social activities. This was in character for both of them. For instance, when Alan was a Fellow of Jesus College, and Alan and Hetty lived in Park Terrace in Cambridge, their drawing room on the first floor had a balcony overlooking Parker's Piece to which students and friends were invited to witness the festivities on Guy Fawkes' night. These occasions made a lasting impression on those fortunate enough to take part. At Fitzwilliam, Alan was keen to row in the Fellows' Boat which enjoyed an active life on the river for a couple of years in the mid-1990s. Many thought that this would be the death of him, and fortunately, after an initial trial, a replacement was found so that Alan lived to tell the tale.
Alan was also the first Master to commit significant time and energy to the business of fundraising, recognizing how essential this was for the future of collegiate Cambridge. He worked hard to establish links around the world, not only in Singapore, where the College already had a strong link through Lee Kuan Yew, but also at the Japan Daiichi University of Economics in Fukuoka. Thanks to Alan's efforts, the latter University agreed to fund the College auditorium, built after Alan's retirement as Master, and to establish a scheme that has provided generations of students with a chance to spend a year living and studying in Japan. Alan took a keen interest in the wider Fitzwilliam community, and both he and Hetty are fondly remembered by the College's alumni association. Throughout his retirement he maintained a loyal presence in Fitzwilliam at alumni reunions, London dinners, and domestic retired Fellows' evenings.
Of course, while Alan was Master of Fitzwilliam, he was also Head of the Department of Pharmacology, sometime Deputy Vice-Chancellor of the University, and very much still active in science. As he acknowledged much later, the efficient running of his lab was only possible thanks to the efforts of a number of graduate students, and especially to the longterm contributions of his postdoctoral research assistant Lesley MacVinish and his technician Margaret Hickman. which discussed the prospects for therapies for CF (20). In 2015 he published his last paper (21) , as first author, aged 83!
